Coronary allograft vasculopathy managed by Flash ostial balloon in a pediatric patient
Viral K Desai1, Mohammad Mathbout2, Apurv Agarwal1
1Department of Internal Medicine, University of Louisville, Louisville KY.
Insights
Coronary allograft vasculopathy (CAV) is a major risk for heart transplant recipients. This case report details a novel percutaneous coronary intervention for pediatric CAV, offering potential for improved outcomes.
Area of Science:
- Cardiology
- Transplantation immunology
- Pediatric cardiology
Background:
- Coronary allograft vasculopathy (CAV) is a leading cause of death in heart transplant recipients, characterized by intimal hyperplasia, atherosclerosis, and inflammation.
- Diagnosis of obstructive CAV can be challenging due to asymptomatic presentation in post-transplant patients.
- The efficacy of percutaneous coronary intervention (PCI) for pediatric CAV remains understudied.
Observation:
- This report presents the first-in-human use of a Flash ostial balloon for stent flaring.
- The intervention was performed in a pediatric patient with a history of orthotopic heart transplant.
- The patient had ostial left main coronary artery disease, a manifestation of CAV.
Findings:
- Successful management of ostial left main coronary artery disease in a pediatric heart transplant recipient using a novel PCI technique.
- The use of a Flash ostial balloon for flaring an ostial coronary stent was demonstrated.
- This approach addressed a challenging manifestation of coronary allograft vasculopathy.
Implications:
- This case suggests a potential new therapeutic option for pediatric patients with CAV.
- Further research is warranted to evaluate the long-term efficacy and safety of this PCI technique in pediatric heart transplant recipients.
- This intervention may improve outcomes and recovery for young patients suffering from CAV.
Abstract:
Coronary allograft vasculopathy (CAV) is the most significant cause of morbidity and mortality in heart transplant recipients. Inflammation and endothelial dysfunction caused by graft rejection and viral infections leads to a combination of circumferential intimal fibromuscular hyperplasia, atherosclerosis, and inflammation affecting all layers of the vessel wall. Though obstructive CAV is often asymptomatic, posing a diagnostic challenge in post-transplant patients, early diagnosis and treatment aid faster recovery and improved outcomes. The role of percutaneous coronary intervention in the treatment of CAV is unknown and not well studied in the pediatric population. We present a first-in-human case of ostial left main coronary artery disease managed with flaring of the ostial coronary stent using a Flash ostial balloon in a pediatric patient with history of an orthotopic heart transplant.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management


